Secondary lymphoid organs (SLOs) provide a niche for the initiation and regulation of T cell responses, but the mechanisms have been poorly understood. We investigated the influence of chemokines CCL19 and CCL21 constitutively expressed in SLOs on activation-induced cell death 
4 such as AICD of activated T cells, is unknown. In the present paper, we analyzed AICD induction in CD4 + T cells in plt/plt mouse in vivo and in vitro. We found that the frequency of apoptotic antigen-specific CD4 + T cells was decreased in the draining LNs of plt/plt mice, when mice were subcutaneously immunized with a protein antigen in complete Freund's adjuvant (CFA).
Additionally, AICD of CD4 + T cells induced by repeated in vitro stimulation via TCR is increased in a dose-dependent manner by additional stimulation with CCL19 or CCL21 in vitro. Our results suggest that CCL19 and CCL21 promote AICD of antigen-specific CD4 + T cells, demonstrating that these chemokines regulate not only T cell mobilization but also their fate after activation.
For personal use only. on April 14, 2017 . by guest www.bloodjournal.org From in the hind footpads with 100µg chicken OVA (Sigma-Aldrich, St. Louis, MO) emulsified in CFA (Difco, Detroit, MI) (OVA/CFA).
Adoptive transfer of antigen-specific naïve CD4 + T cells
Naïve CD4 + T cells were purified from DO11.10 mice. 21 Briefly, CD4 + T cells were isolated from pooled LNs and spleen on a MACS column (Miltenyi Biotec, Auburn, CA) using anti-CD8 (53-6-7.2), -CD11b (M1/70), -CD11c (HL3), -CD49e (DX5), -B220 (RA6-3A1), -MHC class II (39-10-8) and -F4/80 mAbs and rat anti-mouse IgM (Vector, Burlingame, CA). Then high-density naive cells according to the manufacturer's instructions, then 2.5x10 6 cells were intravenously transferred to recipients. The recipients were immunized with OVA/CFA one day after the adoptive transfer.
T cell proliferation assay
Single cell suspensions were prepared from popliteal LNs at indicated days after immunization. culture medium, RPMI-1640 supplemented with 10% FCS, 50µM 2-ME, 10mM Hepes, 50U/ml
For personal use only. on April 14, 2017 . by guest www.bloodjournal.org From For the chemokine-effect tests, 5x10 5 naïve CD4 + T cells prepared from LNs and spleens were cultured in 2 ml complete RPMI-1640 with or without recombinant mouse CCL19, CCL21, CXCL9, CXCL10, CXCL12, CCL3, or CCL4 in the presence or absence of goat anti-mouse CCL19 neutralizing antibodies (R&D Systems, Minneapolis, MN) in 24-well plate coated with 1µg/ml anti-CD3 and 1µg/ml anti-CD28 (eBioscience, San Diego, CA) for 4-days (first culture).
The treated and viable CD4 + T cells were incubated with anti-CD3 mAb+IL-2 as described above (second culture), and assayed for apoptotic cells. Where indicated, the pancaspase inhibitor (Z-VAD-fmk), caspase-8-specific inhibitor (Z-IETD-fmk), or caspase-9-specific inhibitor (Z-LEHDfmk) (ICN Pharmaceuticals, Costa Mesa, CA) was added at 100µM to the second culture.
Flow cytometric analysis
Popliteal LN cells were pre-incubated with anti-FcRγII (2.4G2) and 5% normal mouse and rat sera to avoid nonspecific staining, and treated with the appropriate mAbs. Monoclonal Abs against TCR 
Apoptotic cell analysis
Cells were stained with the appropriate mAbs. After washing with cold PBS, the cells were further stained with FITC-or PE-conjugated AnnexinV (Trevigen, Gaithersburg, MD, or BD Pharmingen, respectively) and propidium iodide (PI) (Trevigen) according to the manufacturer's instructions, and were analyzed by flow cytometry.
Real-time RT-PCR analysis
Total cellular mRNA was isolated from CD4 + T cells using an EASYPrep RNA (Takara Bio, Otsu, Japan) following the manufacturer's instructions. RNA (500ng per 100µl reaction) was reverse transcribed using the High-Capacity cDNA Archive Kit (PE Applied Biosystems, Foster City, CA).
For the quantitative analysis of gene expression, real time PCR was conducted using Taqman@ Gene Expression Assay Kits (PE Applied Biosystems); Mm00433237_m1 for Fas, and
Mm00438864_1 for Fas ligand. Amplification reaction was performed on an ABI Prism 7000
Sequence Detector System (PE Applied Biosystems), under the following cycling protocol: 95˚C for 10 min, followed by 40 cycles of 95˚C for 15s and 60˚C for 1min. Subsequently the threshold cycle (Ct) was determined. As an endogenous reference GAPDH was used for normalization.
Results were expressed as 2 -∆∆ , where ∆CT = Ct of target gene -Ct of endogenous control gene (GAPDH), and ∆∆CT = ∆CT of CCL19/21-stimulated sample -∆CT of unstimulated sample. Thus, all experimental samples are expressed as a n-fold difference to the control. Quantitative real-time PCR experiments were repeated twice in triplicate.
Analysis of transcription factors
Nuclear extract was prepared from CD4 + T cells using TransFactor Extraction Kit (BD Bioscience/CLONTECH), according to manufacturer's instructions. After centrifugation at 20,000xg for 5 min at 4°C, supernatants (nuclear extracts) were assayed for NF-κB p65, NF-κB p50, or c-Jun content. The translocated transcription factors were detected using BD TransFactor Kits (BD Bioscience/CLONTECH). Plates were read at 450nm and expressed as OD values.
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Results

Maintenance of antigen-reactive CD4 + T cells in plt/plt mice
In order to investigate the regulation of the T cell response in vivo, draining popliteal LN cells were prepared from OVA/CFA-immunized mice at various time points, restimulated with OVA in vitro,
and assessed for proliferation. In BALB/c mice, the recall response peaked by day 9 after immunization, and was maintained until day 16 but declined rapidly thereafter (Fig.1) . In plt/plt mice, the recall response remained maximal even 18 or 20 days after immunization. Surprisingly, strong proliferation was still observed 16 months after immunization (Fig.1) .
We also counted the number of CD4 + T cells in the draining LNs (d-LNs). Consistent with a lymphocyte-homing deficiency, the total LN CD4 + T cell number was much lower in plt/plt mice than in BALB/c mice throughout the observation period (Fig.2a) . However, the number of CD4 + T cells in plt/plt mice increased at quite similar rate to that in BALB/c mice after immunization (Fig.2b) . The CD4 + T cell number in the plt/plt mouse never declined during the observation period, while in BALB/c mice it peaked by day 16 and rapidly decreased thereafter (Fig.2a,b) . Also in CCR7-deficient mice, CD4 + T cell number never declined during the observation period (Fig.2c,d ). however, the frequency slightly decreased after immunization and remained low until day 20 (Fig.3a) . Similarly the frequency decreased and remained low until day 24 in CCR7-deficient mice (Fig.3c) .
Figure 1
Figure 3
To further clarify antigen specificity, mice were injected with DO11. whereas the presence of CCL19 or CCL21 in the first culture increased the apoptotic cell frequency in a dose-dependent manner (Fig.5a ). Over 10ng/ml, both chemokines elicited a significant enhancement of apoptosis. At 100ng/ml, CCL19 and CCL21 increased the frequency of apoptotic cells 1.67 and 1.83 times, respectively. CCL19-enhanced apoptosis was completely abolished by neutralizing antibodies against CCL19, indicating that the enhanced apoptosis is mediated by CCL19 (Fig.5b) . However, the presence of CCL19 or CCL21 in the second culture, but not in the first culture, did not alter the frequencies of apoptotic CD4 + T cells, demonstrating that neither CCL19 nor CCL21 influence apoptosis of previously activated CD4 + T cells (Fig.5c ). We tried to confirm the chemokine effect on CD4 + T cell AICD by inhibition with pertussis toxin. However, CD4 + T cells were mostly died during 4-day culture with pertussis toxin at appropriate concentration for inhibition of chemokine effect (data not shown).
We also examined the effect of CXCL9, CXCL10, CXCL12, CCL3, or CCL4 on AICD.
The inclusion of one of these chemokines in the first culture did not enhance AICD of naive CD4 + T cells after restimulation with anti-CD3 mAb and IL-2 (data not shown).
Enhancement of FasL-expression by CCL19 and CCL21
Since Fig.6a and data not shown) . However, FasL expression was clearly increased by repeated activation with anti-CD3 mAb+IL-2, and further enhanced by addition of CCL19 and CCL21 to the first culture (Fig.6a) , suggesting that CCL19 and CCL21 are able to play some role in enhancing FasL expression on CD4 + T cells stimulated with anti-CD3 and anti-CD28 mAbs. This enhancement of FasL expression was confirmed at mRNA level (Fig.6b) . Consistently, DNA binding of the transcription factors, c-Jun and NF-κB, was increased in CD4 + T cells by addition of CCL19 and CCL21 to the first culture (Fig.6c) . This increase has been reported to enhance FasL transcription.
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Wild in WT mice, where apoptosis was increased from 30% to about 50% (Fig.5d) . These results strongly supported the possibility that CCL19 or CCL21 regulates AICD in CD4 + T cells at least partly through Fas-and FasL-dependent pathway.
Involvement of caspase 8 and 9 in the enhancement of sensitivity to AICD by CCL21
To determine the involvement of caspase-8 and -9 in the chemokine-enhanced sensitivity to AICD, BALB/c T cells primed in the presence or absence of CCL21 were restimulated with anti-CD3 mAb and IL-2 in the absence or presence of the caspase-8-specific inhibiter (Z-IETD-fmk), caspase-9-
inhibitor (Z-LEHD-fmk), or pancaspase inhibitor (Z-VAD-fmk). As shown in Figure 7 , when CCL21 was included in the first culture, the ratio of AnnexinV + apoptotic cells was decreased from about 40% to 20% by the addition of the inhibitor for caspase-8 or caspase-9 to the restimulation culture. The ratio was further decreased to about 10%, when the pancaspase inhibitor was present in the restimulation. Similarly, the apoptotic cell ratio in the T cells primed in the absence of CCL21 was decreased from about 30% to 20% in the presence of the inhibitor for caspase-8 or caspase-9, and to 10% in the presence of the pancaspase inhibitor (Fig.7) . These results suggested that the major part of CCL21-enhanced sensitivity to AICD involves caspase-8-mediated and caspase-9-mediated apoptotic pathway.
Figure 7
For
Discussion
Expression of CCL19 and CCL21 in the T cell zone of secondary lymphoid organs where naïve T cells are primed and activated raises the possibility that these chemokines are involved in regulation of T cell responses. [6] [7] [8] The possibility that CCL19/CCL21 are involved in AICD is consistent with our previous finding that T cell immune responses in plt/plt mice are disregulated. 18 Indeed, analysis of Vβ14 Fig.6a and b) . Consistently, an increase in nuclear translocation of transcription factors, c-Jun and NF-κB, was observed (Fig.6c) (Fig.7) . Furthermore, much less enhancement of AICD by CCL19/CCL21 was observed in Fas-or FasL-deficient CD4 + T cells (Fig.5d) . However, reduced enhancement of AICD by stimulation in the presence of CCL19/CCL21 was still detected in these Fas-or FasL-deficient CD4 + T cells, indicating that other pathways are also involved. In accordance, the caspase-9-specific inhibitor decreased in vitro AICD in CD4 + T cells to the similar level obtained with the caspase-8-specific inhibitor (Fig.7a) . Other molecules reportedly involved in AICD and mitochondria-pathway are now under the investigation. with our previous results. 18 The phenotypic analysis also supported our interpretation that the low frequency of AICD in the d-LNs of plt/plt mice is not due to an activation failure. Thus, chemokine receptors including CXCR4, CCR5 and CCR7, seems to share, at least partly, the intracellular signaling pathway. However, CXCR3-, CXCR4-or CCR5-ligand did not affect AICD frequency of CD4 + T cells when added during priming with anti-CD3 and anti-CD28 mAbs, which might be due to low or negligible expression of these chemokine receptors on naive and un-stimulated CD4 + T cells. [49] [50] [51] [52] It is also possible that the signaling pathway of CCR7 could be distinct from that of CXCR4. The exact CCR7-signaling pathway remains to be determined, and will lead to understanding the mechanisms for CCL19/CCL21-enhanced apoptosis.
Our in vitro finding that CCL19/CCL21 enhances T cell apoptosis independently of cell migration strongly suggests that these chemokines directly affect T cells and increase their susceptibility to AICD. Similarly, it has been reported that these chemokines are responsible not only for cellular migration but also for terminal activation of DCs to prime T cell responses. 53 However, it is also possible that these chemokines indirectly affect T cell AICD, especially in vivo.
These chemokines regulate trafficking of T cells and dendritic cells, 16 and efficient interaction between CD4 + T cells and antigen-presenting cells such as dendritic cells is proposed to be necessary for induction of full activation of CD4 + T cells and ultimately for cell death. were assayed for the contents of these factors using BD TransFactor Kits (BD Bioscience/Clontech).
Results were expressed as OD values at 450 nm. were not added, DMSO was employed as a solvent control.
